At a glance
The March 20, 2023, Laboratory Outreach Communication System (LOCS) call included updates on the Marburg virus disease, SARS-CoV-2 variants, FDA, and the use of the Laboratory Preparedness Exercise (LPX) to assess the rule-out/referral capability of clinical laboratories.
Agenda
Archived LOCS Materials Access
Welcome: Sean Courtney, CDC Division of Laboratory Systems
Marburg Virus Disease Update: Joel Montgomery, CDC Division of High Consequence Pathogens and Pathology
SARS-CoV-2 Variants Update: Natalie Thornburg, CDC Coronavirus and Other Respiratory Viruses Division
FDA Update: Timothy Stenzel, U.S. Food and Drug Administration
Use of Laboratory Preparedness Exercise (LPX) to Assess Rule-Out/Referral Capability of Clinical Laboratories: Chris N. Mangal, Association of Public Health Laboratories
This page was last updated on this date. Updates may include minor edits, image changes, or other modifications to page content.
The information on this page was last reviewed by subject matter experts to ensure accuracy.